Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.97 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.97 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.97 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.97 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.97 |
| ▸ | SERPINE1 | P05121 | 3/20 | 0.77 |
| ▸ | CNR2 | P34972 | 2/20 | 0.67 |
| ▸ | CNR1 | P21554 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9061046 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Octadecyl Gallate SCHEMBL51646 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Dodecyl Gallate SCHEMBL7566739 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Nonyl Gallate SCHEMBL1260820 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL2223395 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Dodecyl Gallate SCHEMBL36820 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Octyl_Gallate SCHEMBL36234 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Tetradecyl Gallate SCHEMBL221375 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Undecyl Gallate SCHEMBL2219566 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Dodecyl Gallate SCHEMBL20450223 | 0.98 | ESR1 (1.00) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577375-B2 | Water-soluble composition comprising lysophosphatidylethanolamine and having improved stability, and method for preparing the same | LG CHEM, LTD. (KR) | 2026-03-17 | — | — | US | claimed |
| US-20250275997-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BONAFIDE HEALTH, LLC | 2025-09-04 | — | — | US | claimed |
| EP-4604931-A1 | COMPOSITIONS OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND AN ANTIOXIDANT | Merck Sharp & Dohme LLC (US) | 2025-08-27 | — | — | EP | claimed |
| CN-120021641-A | Composition containing plant essential oil and benzyl isothiocyanate, preparation and application | 西北农林科技大学 | 2025-05-23 | — | — | CN | claimed |
| US-12303524-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | MSI-195 HOLDINGS, LLC (US) | 2025-05-20 | — | — | US | claimed |
| WO-2024128554-A1 | METHOD FOR PREPARING CARBON DIOXIDE-EPOXIDE REACTION CATALYST, CARBON DIOXIDE-EPOXIDE REACTION CATALYST, AND POLYMER SYNTHESIS METHOD | 아주대학교산학협력단 | 2024-06-20 | — | — | WO | claimed |
| WO-2024086263-A1 | COMPOSITIONS OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND AN ANTIOXIDANT | MERCK SHARP & DOHME LLC (US) | 2024-04-25 | — | — | WO | claimed |
| US-20230374269-A1 | WATER-SOLUBLE COMPOSITION COMPRISING LYSOPHOSPHATIDYLETHANOLAMINE AND HAVING IMPROVED STABILITY, AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2023-11-23 | — | — | US | claimed |
| CN-114807920-B | Preparation of rust conversion agent | 浙大宁波理工学院 | 2023-11-21 | — | — | CN | claimed |
| CN-113996781-B | Soft magnetic composite material and preparation method thereof | 内蒙金属材料研究所 | 2023-10-13 | — | — | CN | claimed |
| EP-2381797-A1 | ANIMAL FEED ADDITIVE AND ANIMAL FEED COMPRISING ALKYL ESTERS OF MEDIUM CHAIN FATTY ACIDS, AND THEIR USE IN ANIMAL FEED | Nutreco Nederland B.V. (NL) | 2011-11-02 | — | — | EP | claimed |
| EP-2215913-A1 | Animal feed additive and animal feed comprising alkyl esters of medium chain fatty acids, and their use in animal feed | Nutreco Nederland B.V. (NL) | 2010-08-11 | — | — | EP | claimed |
| WO-2010085149-A1 | ANIMAL FEED ADDITIVE AND ANIMAL FEED COMPRISING ALKYL ESTERS OF MEDIUM CHAIN FATTY ACIDS, AND THEIR USE IN ANIMAL FEED | NUTRECO NEDERLAND B.V. (NL) | 2010-07-29 | — | — | WO | claimed |
| US-20100143490-A1 | COMPOSITE MATERIAL | NOVA THERA LIMITED (GB) | 2010-06-10 | — | — | US | claimed |
| US-20100136131-A1 | COMPOSITE MATERIAL | NOVATHERMA LIMITED (GB) | 2010-06-03 | — | — | US | claimed |
| EP-2054091-A2 | COMPOSITE MATERIAL COMPRISING FIBRINOGEN AND BIOACTIVE GLASS AS A WOUND DRESSING | Novathera Limited (GB) | 2009-05-06 | — | — | EP | claimed |
| EP-2054092-A2 | COMPOSITE MATERIAL | Novathera Limited (GB) | 2009-05-06 | — | — | EP | claimed |
| WO-2008023165-A2 | COMPOSITE MATERIAL | NOVATHERA LIMITED (GB) | 2008-02-28 | — | — | WO | claimed |
| WO-2008023163-A2 | COMPOSITE MATERIAL COMPRISING FIBRINOGEN AND BIOACTIVE GLASS AS A WOUND DRESSING | NOVATHERA LIMITED (GB) | 2008-02-28 | — | — | WO | claimed |
| EP-1604660-A1 | MEDICINAL COMPOSITION FOR TREATING INFECTION WITH DRUG-RESISTANT STAPHYLOCOCCUS AUREUS | Alps Pharmaceutical Ind. Co. Ltd. (JP) | 2005-12-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275997-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BHMT2, BHMT, MAT1A | ESR1 598/4885AKR1C4 1989/4885AKR1C3 1733/4885 |
| US-12303524-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | BHMT2, BHMT, MAT1A | ESR1 598/4885AKR1C4 1989/4885AKR1C3 1733/4885 |
| US-12577375-B2 | Water-soluble composition comprising lysophosphatidylethanolamine and having improved stability, and method for preparing the same | PCTP, PHOSPHO1, SGMS1 | ESR1 3096/4885AKR1C4 2874/4885AKR1C3 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.